55.01USD-2.73%Mkt Cap: 10.64B USDP/E: 39.59Last update: 2026-06-01
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap10.64B USD
Enterprise Value10.29B USD
Revenue (TTM)3.24B USD
Gross Profit2.50B USD
Net Income (TTM)348.90M USD
Revenue/Share16.87 USD
Last Price55.01 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS09061G1013
Valuation
P/E (Trailing)39.59
P/E (Forward)8.90
PEG0.64
EV/EBITDA16.30
EV/Revenue3.17
P/S3.42
P/B1.78
EPS (TTM)1.39
EPS (Forward)6.44
52W Range
49.2634% of range66.28
52W High66.28 USD
52W Low49.26 USD
Profitability
Gross Margin77.73%
Oper. Margin18.00%
EBITDA Margin19.47%
Profit Margin10.83%
ROE5.73%
ROA4.59%
Growth
Revenue Growth2.80%
Earnings Growth-43.10%
Cash Flow & Leverage
Operating CF827.99M USD
CapEx (TTM)110.97M USD
FCF Margin14.17%
FCF Yield4.32%
Net Debt-782.83M USD
Net Debt/EBITDA-1.24
Balance Sheet
Debt/Equity0.10
Current Ratio5.81
Quick Ratio3.94
Book Value/Sh32.14 USD
Cash/Share11.50 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)87.85 USD
Target Range50.00 USD – 120.00 USD
# Analysts26
Ownership
Shares Out.193.28M
Float192.17M
Insiders0.30%
Institutions102.74%
Short Interest
Short Ratio6.4d
Short % Float5.89%
Short % Out.5.88%
Shares Short11.36M
Short (prev mo.)10.15M
Technical
SMA 5054.18 (+1.5%)
SMA 20055.83 (-1.5%)
Beta0.23
S&P 52W Chg27.94%
Avg Vol (30d)1.96M
Avg Vol (10d)2.45M
Technical Indicators
RSI (14)61.0
MACD-0.2308
MACD Signal-0.6480
MACD Hist.+0.4173
BB Upper56.61 USD
BB Middle53.11 USD
BB Lower49.60 USD
BB Width13.20%
ATR (14)1.822 USD
Vol Ratio (20d)1.06x